{"id":"clm_9CE71799FE73","entity":"astrazeneca","predicate":"operating_income","value":"4,114,000,000 United States dollar","value_json":{"fy":2017,"accn":"0001104659-18-015257","form":"20-F","filed":"2018-03-06","concept":"ifrs-full:ProfitLossFromOperatingActivities"},"valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2018-03-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca operating income: 4,114,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_9CE71799FE73, https://asof.is/claim/clm_9CE71799FE73, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm.","url":"https://asof.is/claim/clm_9CE71799FE73","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_654CC8AE2812","supersedes":[],"first_seen_at":"2026-11-08T15:36:59.840457+00:00","updated_at":"2026-11-08T15:36:59.840457+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2017","published_at":"2018-03-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2017, filed 2018-03-06"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}